Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine von Kazmi, Shayma, Chatterjee, Debanjana, Raju, Dheeraj, Hauser, Rob, Kaufman, Peter A.

Volltext

Correction to: Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine von Kazmi, Shayma, Chatterjee, Debanjana, Raju, Dheeraj, Hauser, Rob, Kaufman, Peter A.

Volltext

Malignant phyllodes tumor in Lynch syndrome: a case report von Kazmi, Shayma, Wagner, Steven, Heintzelman, Rebecca, Corbman, Melanie

Volltext

The Role of Antibody-Drug Conjugates in Non-Small Cell Lung Cancer von Kazmi, Shayma Master

Volltext

My Transformational Experience in a Physician Forum Group von Kazmi, Shayma, Ferraro, Jay

Volltext

Overall survival analysis in patients with metastatic breast cancer and liver or lung metastases treated with eribulin, gemcitabine, or capecitabine (vol 184, pg 559, 2020) von Kazmi, Shayma, Chatterjee, Debanjana, Raju, Dheeraj, Hauser, Rob, Kaufman, Peter A.

Volltext

PS01.54: Evaluation of Novel Blood-Based Biomarkers with Atezolizumab Monotherapy in 1L Advanced or Metastatic NSCLC (B-F1RST) von Socinski, Mark A., Schiller, Joan, Dakhil, Shaker, Kazmi, Shayma, Leach, Joseph, Hu, Sylvia, Paul, Sarah M., Shames, David S., Phan, See, Yun, Cindy, Velcheti, Vamsidhar

Volltext

PS01.54: Evaluation of Novel Blood-Based Biomarkers with Atezolizumab Monotherapy in 1L Advanced or Metastatic NSCLC (B-F1RST): Topic: Medical Oncology von Socinski, Mark A., Schiller, Joan, Dakhil, Shaker, Kazmi, Shayma, Leach, Joseph, Hu, Sylvia, Paul, Sarah M., Shames, David S., Phan, See, Yun, Cindy, Velcheti, Vamsidhar

Volltext